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Abstract
Several shorter analogues of the cell penetrating peptide, transportan, have been synthesized in order to define the regions
of the sequence, which are responsible for the membrane translocation property of the peptide. Penetration of the peptides
into Bowes melanoma cells and the influence on GTPase activity in Rin m5F cellular membranes have been tested. The
experimental data on cell penetration have been compared with molecular modeling of insertion of peptides into biological
membranes. Omission of six amino acids from the N-terminus did not significantly impair the cell penetration of the peptide
while deletions at the C-terminus or in the middle of the transportan sequence decreased or abolished the cellular uptake.
Most transportan analogues exert an inhibitory effect on GTPase activity. Molecular modeling shows that insertion of the
transportan analogues into the membrane differs for different peptides. Probably the length of the peptide as well as the
location of aromatic and positively charged residues have major impact on the orientation of peptides in the membranes and
thereby influence the cellular penetration. In summary, we have designed and characterized several novel short transportan
analogues with similar cellular translocation properties to the parent peptide, but with reduced undesired cellular
activity. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Today most approaches for delivering polar or
large molecules such as peptides, proteins, antisense
oligonucleotides etc. into cells use endocytosis, elec-
troporation or microinjection techniques. These
methods are limited by either in vitro applicability
only or by low yield of cargo delivery and degrada-
tion of targeted molecules.
An alternative method for cellular delivery of bio-
active cargoes is to use vector peptides i.e. peptides
that interact with the plasma membrane and trans-
locate into the cellular interior e.g. mastoparan [1],
the fragments of antennapedia of Drosophila (pene-
tratins) [2,3], transportan (TP) [4], Tat protein [5,6],
herpes virus structural protein VP22 [7] etc. Trans-
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port peptides have been shown to deliver peptides [8],
small proteins [9], DNA [10] oligomers and peptide
nucleic acid (PNA) [11] oligomers over the plasma
membrane by a non-endocytotic mechanism. How-
ever, the mechanism of penetration of these peptides
and their constructs with large molecules still re-
mains unknown.
TP, a representative of the cell-penetrating pepti-
des, is a 27 amino acids long chimeric peptide con-
taining the ¢rst 12 amino acids from the amino-ter-
minal part of neuropeptide galanin and the 14 amino
acid long wasp venom peptide, mastoparan, con-
nected via a lysine residue [4]. It has been shown
that TP rapidly enters cells by a receptor-independ-
ent mechanism [4]. Later TP has been shown to be
able to deliver antisense PNA oligomers into cells
[11]. TP contains the N-terminal part of the bioactive
neuropeptide galanin and is therefore recognized by
galanin receptors. Moreover, TP shows an inhibitory
e¡ect on basal GTPase activity in Bowes melanoma
cell membranes, which is probably caused by the
mastoparan part of the molecule. Although the in-
hibitory e¡ect of TP is detectable at higher concen-
trations than commonly used in delivery experi-
ments, this feature could be a drawback for carrier
peptide. Therefore we have studied the structural re-
quirements for the cell membrane penetrating activ-
ity of TP. We have synthesized nine novel truncated
derivatives of TP aiming at minimizing the a⁄nity
for galanin receptors and the interaction with G-pro-
teins and, if possible, to enhance cell penetration
e⁄ciency of the peptide. The resulting peptides
have been tested for cellular uptake by Bowes mela-
noma cells by using indirect immuno£uorescence and
125I-labeled peptides. The e¡ect of TP and its short
analogues on the basal GTPase activity was studied
in Rin m5F cell membranes.
The interaction of peptides with biological mem-
branes was simulated by molecular modeling and the
penetration as well as orientation of nine TP ana-
logues in relation to the membrane surface was cal-
culated [16]. The simulations reveal that the insertion
and the relative orientation of short TP analogues in
phospholipid membranes are remarkably di¡erent
for di¡erent peptides.
2. Materials and methods
2.1. Peptide synthesis
The peptides were synthesized in a stepwise man-
ner in a 0.1 mmol scale on a model 431A peptide
synthesizer (Applied Biosystems, USA) using t-Boc
strategy of solid-phase peptide synthesis. tert-Butyl-
oxycarbonyl amino acids were coupled as hydroxy-
benzotriazole (HOBt) esters to a p-methylbenzylhy-
drylamine (MBHA) resin (Bachem, Switzerland) to
obtain C-terminally amidated peptides. Biotin was
coupled manually to the O-amino group of Lys after
orthogonal deprotection from the Fmoc-group, using
a three-fold excess of HOBt and o-benzotriazole-1-
yl-N,N,NP,NP-tetramethyluronium tetra£uoroborate
(TBTU) activated biotin (Chemicon, Sweden) in
DMF to the peptide on resin. Deprotection of the
side chains from formyl and benzyl groups was car-
ried out using the ‘low TFMSA’ method. The pep-
tides were cleaved from the resin with liquid HF at
0‡C for 30 min in the presence of p-cresol.
The purity of the peptides was s 98% as demon-
strated by HPLC on an analytical Nucleosil 120-3
C18 RP-HPLC column (0.4U10 cm). The molecular
masses of the peptides were determined with a plas-
ma desorption mass spectrometer (Bioion 20, Ap-
plied Biosystems, USA) and the calculated values
were obtained in each case.
2.2. Iodination
Peptide iodination was carried out by the chlor-
amine T method [12]. Na125I (speci¢c activity 16.1
mCi/mg, concentration 0.1 mCi/ml) was mixed with
¢ve equivalents of the peptide in phosphate bu¡er 50
mM, pH 7.4). The reaction was carried through for
2 min and stopped by adding an excess of sodium
metabisul¢te. The iodinated peptides were separated
from free label by chromatography on a reversed
phase (RP), column SEP-PAK 51910 (Millipore,
USA) using a stepwise gradient of acetonitrile. The
fractions containing the highest speci¢c activity
(eluted with 40% acetonitrile) were used for a cell
penetration assay.
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2.3. Cells
The human Bowes melanoma cell line (ATCC
CRL-9607) was cultivated in minimal essential me-
dium with Earl-salts (MEM) supplemented with 10%
fetal calf serum, 2 mM L-glutamine, 5 IU/ml penicil-
lin and 5 Wg/ml streptomycin in air with CO2 en-
riched to 5% at 37‡C. The cells were grown on round
glass coverslips in a 24 well plate to approximately
50% con£uence. Binding of 125I-galanin to the Bowes
cellular membranes was carried out as described ear-
lier [4].
2.4. Cellular penetration of biotinyl-labeled peptides
The serum-containing medium on the cells was
exchanged for a serum-free and the water solution
of the biotinyl-peptides was added directly into the
medium. The cells were then incubated for di¡erent
time periods at 37‡C and unbound peptide was re-
moved by washing twice with PBS. The cells were
¢xed with 4% paraformaldehyde in PBS for 30 min
at room temperature, permeabilized with cold meth-
anol for 10 min at 320‡C. Permeabilized cells were
washed with PBS and incubated for 1 h in 5% (w/v)
solution of bovine serum albumin in PBS in order to
decrease unspeci¢c binding. The peptides were visu-
alized by staining with streptavidin-FITC (Amer-
sham-Pharmacia Biotech, 1:100 dilution) in the
same solution for 1 h at room temperature. The
cell nuclei were stained with Hoechst 33258 (0.5 Wg/
ml) for 5 min, the coverslips were washed ¢ve times
with PBS and mounted in ‘Prolong’ antifade reagent
(Molecular Probes, USA). The images were obtained
by Zeiss Axioplan 2 microscope (Carl Zeiss, Ger-
many) equipped with a cooled digital CCD camera
C4880 (Hamamatsu Photonics, Japan) or by a laser
scanning confocal microscope (model LSM 510; Carl
Zeiss, Sweden) equipped with an Ar laser (488 nm), a
He/Ne laser (543 nm), a 63U1.4 oil immersion ob-
jective. The Ar and He/Ne lasers were operated at
8% and 60% power, respectively. Images were pro-
cessed using Adobe Photoshop 3.0 software (Adobe
Systems, CA, USA).
2.5. Cellular penetration of 125I-labeled peptides
Bowes cells were grown to 70^80% con£uence in a
75 cm2 £ask. The cells were scraped o¡ and centri-
fuged at 1500 rpm for 10 min. The supernatant was
discarded and the pellet resuspended in 2 ml HEPES
bu¡ered Krebs Ringer solution (HKR) pH 7.4 (5
mM HEPES, 137 mM NaCl, 2.68 mM KCl, 2.05
mM MgCl2, 1.8 mM CaCl2) with the addition of
phosphate bu¡er and 1 mg/ml BSA. The cell suspen-
sion was aliquoted and the radiolabeled peptides
were added to reach an activity of 1 000 000 cpm/
tube. The suspensions were incubated by mild shak-
ing in a water bath at 37‡C up to 240 min, and
centrifuged through a mixture of 40% dioctyl phta-
late and 60% dibutyl phtalate to separate cell-bound
and free radioactivity. The loosely bound 125I-labeled
peptides were detached from the cells by incubation
in ice-cold 0.2 M acetic acid, 0.5 M NaCl (pH 2.5)
for 5 min, in order to distinguish from internalized/
membrane-inserted fraction of peptides. The acid-la-
bile binding of labeled peptide comprised only about
2^3% of the total amount of cell associated peptide.
This di¡erence did not substantially change the ki-
netics of the uptake of radioactively labeled peptide
and therefore in most experiments the step of wash-
ing of cells in acidic conditions was omitted. The
fractions were counted in a Q-counter (Packard, Mer-
iden, CT). Part of the cells was treated analogously
with Na125I instead of the peptide as a control in
order to estimate the intactness of cells in suspension
in the course of incubation.
2.6. Modeling of internalization of 125I-peptides
In the simulation of uptake of TP analogues
by Bowes cells we calculated the half-lives of inter-
nalization using the approximation that the inter-
nalization is a ¢rst order process in accordance
with Eq. 1:
Aÿ!k B 1
where A and B are concentrations of 125I-peptides
outside and inside the cells, respectively, and k is
the ¢rst-order rate constant of the internalization
process. Curve ¢tting and calculations were per-
formed using Prism computer program (GraphPad
Software, USA)
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2.7. Measurement of GTPase activity
Measurement of GTPase activity was performed
radiometrically according to Cassel and Selinger
[13], with the modi¢cations suggested by McKenzie
and co-workers [14]. To the diluted membranes the
ice cold reaction cocktail containing ATP (1 mM),
5P-adenylyl imido-diphosphate (1 mM), ouabain (1
mM), phosphocreatine (10 mM), creatine phospho-
kinase (2.5 Units/ml), dithiothreitol (4 mM), MgCl2
(5 mM), NaCl (100 mM), and trace amounts of [Q-
32P]GTP to yield 50 000^100 000 cpm in an aliquot of
the reaction cocktail (with the addition of cold GTP
to reach the required total concentration GTP of 0.5
WM) was added. Incubation medium was standard
TE-bu¡er (10 mM Tris^HCl, 0.1 mM EDTA), pH
7.5. Background low-a⁄nity hydrolysis of [Q-
32P]GTP was assessed by incubating parallel tubes
in the presence of 100 WM GTP. Blank values were
determined by the replacement of the Rin m5F mem-
brane solution with assay bu¡er. GTPase reaction
was started by transfer of the reaction mixtures to
30‡C water-bath for 12 min. Unreacted GTP was
removed by the 5% suspension of the activated char-
coal in 20 mM H3PO4. The radioactivity of the yield-
ing radioactive phosphate was determined in the
LKB 1214 Rackbeta or in Packard 3255 liquid scin-
tillation counter. The basal GTPase activity of the
Rin m5F cellular membrane preparation was 1.9
pmol/min/mg protein.
2.8. Partition of 125I-labeled TP and its analogues
between octanol and water
125I-labeled peptides were used to determine the
partition coe⁄cients for TP and its analogues in a
water/octanol system. 20 nM water solution of a
peptide and equal volume of water saturated 1-octan-
ol were mixed and vortexed. The phases were sep-
arated by centrifugation for 5 min at 10 000Ug.
Samples were prepared in triplicates and were
counted in a Q-counter.
2.9. Membrane interaction modeling
The structure of each peptide (Table 1) was pre-
dicted using the Stereoalphabet algorithm and en-
ergy-re¢ned with the Simplex procedure. This latter
calculation was carried out in a medium of inter-
mediate dielectric constant of a hydrophobic/hydro-
philic interface [15]. The penetration and orientation
of TP analogues in a biological membrane were
tested using the Impala software [16]. Calculations
were performed on RAMSES (rapid analysis mas-
ter/salves extensible system), parallel hardware of
21 Tracor Europa Pentium Pro PC connected by a
100 Mb network and controlled by a HP Vectra VA
Pentium Pro. The calculation software has been de-
veloped in our laboratory [16]. Molecular visualiza-
tions were performed using WinMGM 2.0 software
[17] from Ab Initio Technology (Obernai, France).
Non-peptidic parts of molecules (biotin, amide group
at the C-terminal end) were added using the Hyper-
chem 5.0 software (Autodesk, Sausalito, Ca, USA).
3. Results
3.1. Design and synthesis of TP and its analogues
In order to obtain the shortest TP analogue with
minimal biological activities, we synthesized three
series of analogues di¡ering in the positions of the
deletions. In the ¢rst series we deleted amino acid
residues from the N-terminus of TP by three residues
at a time to yield a three, six or nine amino acid
residues shorter peptide. The second series consists
of peptides that lack amino acid residues at the N-
terminus and in the middle of the sequence. In the
third group, presented so far only by the peptide
TP15, the amino acids are missing at the N- and
C-terminus as well as in the middle of the TP se-
quence. All synthesized peptides were biotinylated
at Lys(O-NH) in the galanin-derived part of the mol-
ecule in order to facilitate determination of their in-
tracellular localization by indirect immuno£uores-
cence.
3.2. Penetration of TP analogues into Bowes
melanoma cells
Most of the short TP analogues have retained the
cell penetrating ability. However the new derivatives
di¡er remarkably in the speed and e⁄ciency of pen-
etration as well as in cellular localization. Incubation
of Bowes cells with biotinylated analogues of TP at
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Table 1
Amino acid sequences of galanin, mastoparan (MP), TP and its deletion analogues
Sequence Lengtha
(aa)
Cellular uptaked K-helix
(%)
Angleb
(‡)
Penetrationc
(Aî )
Speed of
uptake
(d0:5, min)
GTPase
activity
(IC50,
WM)
Partition
water/
octanol
0‡C 37‡C
Galanin GWTLNSAGYLLGPHAVGNHRSFSDKNGLTSe 30 3 +/3 88.8
MP INLKALAALAKKILf 14 + + nd
TP GWTLNSAGYLLGKgINLKALAALAKKIL 27 +++ +++ 32 65 31.7 3.4 22 15.1
TP7 ...LNSAGYLLGKgINLKALAALAKKIL 24 +++ +++ 35 48 39.1 4.3 nd 10.4
TP8 .........LLGKgINLKALAALAKKIL 18 3 +/3 41 50 310.4 nd nd nd
TP9 GWTLNSAGYLLGKg..LKALAALAKKIL 25 +++ +++ 46 55 36.4 6.5 47 7.0
TP10 ......AGYLLGKgINLKALAALAKKIL 21 +++ +++ 37 34 311.8 8.6 no e¡ect 9.3
TP11 GWTLNS......KgINLKALAALAKKIL 21 + + 38 65 314.4 nd nd nd
TP12 ...LNSAGYLLGKg..LKALAALAKKIL 22 ++ ++ 50 30 314.4 10.7 58 8.2
TP13 ...LNSAGYLLGKg....ALAALAKKIL 20 3 +/3 29 70 37.6 nd nd nd
TP14 ......AGYLLGKg..LKALAALAKKIL 19 ++ ++ 42.5 38 4.2 nd 69 7.3
TP15 ...LNSAGYLLGKg..LKALAALAK... 19 3 +/3 37 51 39.3 nd nd nd
Comparison of molecular modeling data and the experimental cellular uptake of the peptides.
aNumber of amino acid residues.
bCalculated angle of the peptide in relation to the membrane surface.
cFor the penetration, a value of zero is attributed to the center of the membrane. The penetration is the distance between the mass center of the peptide and this
point (Aî , Fig. 1). A negative value indicates that the mass center of the peptide lies in the ¢rst lea£et of the membrane and a positive value that the molecule reached
the second lea£et.
dDetection of biotin by indirect immuno£uorescence: ‘+++’ denotes comparable, ‘++’ or ‘+’ decreased and ‘+/3’ weak uptake in relation to that of transportan.
eBiotinyl-Gly-Gly-NO25galanin(1^29).
f Biotinylated at the N-terminus.
gBiotinylated at O-amino group of Lys.
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0 or 37‡C for 30 min revealed di¡erences in internal-
ization properties as demonstrated by indirect immu-
no£uorescence (Fig. 1 and Table 1). Deletion of three
or six residues from the N-terminus of TP (TP7 and
TP10, respectively) or two residues from the middle
(TP9) did not in£uence the penetration e⁄ciency of
the peptides, since they internalized to a comparable
degree with TP at both temperatures tested. All three
peptides could be detected all over the cytoplasm and
nucleus of Bowes cells, accumulating mainly in the
intracellular membranous structures (e.g. endoplas-
mic reticulum and Golgi complex) and nuclear enve-
lope. However, the localization of these three pepti-
des is not identical since the TP9 peptide showed
strong staining of the nuclear envelope and distinct
loci in the nucleus whereas TP7 and TP10 are dis-
tributed more evenly in the nucleus as judged by the
di¡use staining.
Further shortening of the N-terminal part led to
the loss of penetration ability, deletion of nine amino
acid residues from the N-terminus (TP8) abolished
the cellular penetration. Deletions from the N-termi-
nus and/or from the middle of the TP molecule de-
creased (TP12, TP14, and TP11) or abolished (TP13)
the internalization. Localization of peptides TP12,
TP14 and TP11 in Bowes cells resembles to the cel-
lular localization of TP9 i.e. peptides associate
mainly with the plasma membrane, intracellular
Fig. 1. Penetration of TP, TP10, TP14, TP7, TP11 and TP8 into Bowes melanoma cells visualized by staining with streptavidin-FITC.
Cells were incubated with 10 WM biotinylated peptides at 37‡C for 60 min.
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membrane structures and are detectable in the nu-
cleus.
Combination of deletions in the N- and C-termini
and also in the middle of the sequence completely
inactivated the peptide, TP15 did not internalize at
all.
In order to compare the rate as well as the yield of
internalization of di¡erent short analogues of TP,
characteristic half times of internalization were cal-
culated from Eq. 1. TP itself is the quickest penetra-
tor with a half time of d0:5 = 3.4 min. Deletion ana-
logues of TP show somewhat slower internalizations
with characteristic half times: d0:5 = 4.3, 8.6, 6.5 and
10.7 min for TP7, TP10, TP9 and TP12, respectively.
3.3. E¡ects of TP analogues on GTPase activity in
Rin m5F cell membranes
It has been shown that TP inhibits the basal activ-
ity of GTPase in Bowes cell membranes (IC50 of 21
WM) [4]. We have studied the in£uence of TP and its
most e⁄ciently penetrating analogues on the GTPase
activity in Rin m5F cell membranes (Fig. 2) with the
further aim to use the peptide that least a¡ects
GTPase activity as carriers of antisense peptide nu-
cleic acid oligomers in this particular cell line. TP,
TP9 and TP12 all inhibit basal GTPase activity in an
analogous manner, IC50 values of 22, 47 and 58 WM,
respectively. TP14 shows a biphasic e¡ect, a small
activation at low concentration, followed by inhibi-
tion with IC50 of 69 WM. The inhibitory e¡ect of
those peptides on the GTPase activity is probably
caused by direct interaction of peptides with G-pro-
teins as was previously shown for galanin(1-13)-mas-
toparan chimera, galparan [18]. These analogues of
TP are mostly located in the membranous structures
of the cell and may therefore change its physical
properties and modulation of GTPase activity, this
could also be caused by indirect i.e. membrane-medi-
ated interaction of the peptides with G-proteins. Sur-
prisingly, the peptide TP10 had no e¡ect on the ac-
tivity of the GTPases at least up to a 0.1 mM
concentration.
3.4. Partition of 125I-labeled analogues of TP between
water and 1-octanol
The concentrations of short analogues of TP were
found to be higher in water (c1) than in octanol (c2)
in partition experiments. TP itself had the highest
partition coe⁄cient value of Pow = 15.1, (P = c1/c2),
and the coe⁄cients for analogues were found to be
between 7.0 and 10.4 (Table 1). Considering that
125I3 ion from Na125I has a partition coe⁄cient of
about 500, these results indicated that TP and its
shorter analogues are clearly lipophilic. The studied
peptides may enter the plasma membranes and could
be better membrane-entering compounds than TP
itself, if the lipophilicity model can be taken as de-
terminant of the cellular penetration properties of a
peptide. However, the water/octanol system does not
take all the aspects of peptide-lipid interaction into
consideration and should be interpreted with cau-
tion.
3.5. Molecular modeling of the interaction of TP
analogues with membranes
The central parts of all the peptides adopt a K-
helical structure (Table 1). This is most pronounced
for the longer molecules, TP9 and TP7. The structure
Fig. 2. GTPase activity in the presence of TP (F), TP10(O),
TP9(S), TP12(*) and TP14(a) in Rin m5F cell membranes.
Points represent the mean values of three independent experi-
ments. Curve for TP, TP10, TP9, TP12 was obtained by ¢tting
the sigmoidal dose-response equation and for TP14 by ¢tting a
double-phase sigmoidal dose-response equation to the experi-
mental data. Concentration of GTP was 0.5 WM.
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of shorter peptides is less de¢ned. The TP8 peptide
(18 amino acids) has an almost entirely coiled con-
formation. In all cases, the N- and C-termini are in
coiled structures, especially the N-terminal domains
of TP15, TP10 and L266 peptides. Nevertheless,
coiled conformation is stabilized in the TP9 peptide
by ‘Z-stacking’ interactions between the aromatic
side chains of tyrosine and tryptophan residues. At
the C-terminus of TP7, TP8 and TP14 peptides, the
carbonyl group interacts with the amino group of the
last but one lysine residue according to the speci¢c
sequence.
In previous studies, calculations showed that the
[N13O-biotinyl]TP could span the membrane at an
angle of 65‡ in relation to the surface plane. In this
study we have analyzed cellular penetration of nine
TP analogues. Molecular modeling shows that all
these peptides are buried into the simulated biologi-
cal membrane with di¡erent orientation. Therefore,
we tried to group the results according to the angle
and depth of penetration into the membrane (Table 1
and Fig. 3). This classi¢cation is tightly in correlation
with the peptide sizes. The peptides TP7 and TP9
have rather similar orientation in the simulated mem-
brane with TP. The main di¡erence is the penetration
depth: TP7 and TP9 peptides do not span the phos-
pholipid bilayer although the molecules are entirely
buried into the membrane. They both display oblique
orientations relatively to the membrane plane with
angles of 48 and 55‡, respectively. The second group
consists of peptides TP10, TP12 and TP14. They in-
sert into the ¢rst lea£et only and lay more parallel in
relation to the membrane surface (angles of 34, 30
and 38‡ respectively). The third subfamily contains
the shortest peptides: TP11 (21 residues), TP13 pep-
tides (20 residues), TP15 (19 residues) and TP8 (18
residues). The modeling predicts that the ¢rst two
peptides exhibit almost perpendicular orientations
in relation to the membrane surface (65 and 70‡,
respectively). The helical domain of the TP11 peptide
is buried into the membrane whilst its coiled N-ter-
minal part remains in the solution phase. The C-ter-
minal part of TP13 peptide reaches the second lea£et
while the biotinyl group and tyrosine residue stay in
Fig. 3. Interaction of calculated peptides with the membrane model. The orange line denotes the center of the bilayer (z = 0). For the
yellow line z = 13.5 Aî and for the green line z = 18 Aî . The environment is completely hydrophilic between green and yellow lines and
completely hydrophobic between two yellow lines. Orientation of TP7, TP9, TP10 and TP13 in relation to the membrane surface and
calculations of MHP, around the peptides in the same orientations.
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the peripheral polar area of the ¢rst lea£et. The
shortest peptides (TP8 and TP15) display di¡erent
oblique orientations (50 and 51‡, respectively) but
stay in the ¢rst lea£et because of their small size.
The N-terminal part of TP8 peptide and the C-ter-
minal part of TP15 peptide remain in the solution
phase. In this meaning TP15 is exceptional as it is
inserted into the membrane with the N-terminal part.
4. Discussion
TP is shown to penetrate into di¡erent cell types in
a rapid and e⁄cient way. The penetration is energy
independent and not receptor-mediated [4]. TP is a
ligand to galanin receptors (KD = 17.4 nM in Bowes
cell membranes) and also inhibits basal GTPase ac-
tivity [4]. We have now synthesized nine shorter TP
analogues to ¢nd a new transport peptide not recog-
nized by galanin receptors and with less in£uence on
the activity of cellular enzyme systems than the pa-
rent peptide, TP. We studied the cellular uptake of
the peptides using the indirect immuno£uorescence
method.
Deletion of up to six amino acids from the N-ter-
minus of TP (galanin part) did not impair the pene-
tration ability of the peptides. These results, as well
as the fact that the peptides are taken up at 4‡C,
show that the uptake of truncated TP analogues is
not mediated by endocytosis of galanin receptors. It
has been shown previously that Trp2, Asn5 and Tyr9
are major pharmacophores in galanin(1-16) neces-
sary for high a⁄nity binding of this N-terminal frag-
ment to the galanin receptor [19] (KD = 3^7 nM for
galanin(1^16), cf. review [20]). Furthermore, recently,
di¡erent groups have shown that deletion of two ¢rst
amino acids of galanin sequence results in an at least
1000-fold decrease in binding a⁄nity of resulting gal-
anin(3-29) to all three known di¡erent subtypes of
galanin receptors (cf. review [21]). The KD values
for N-terminally truncated TP analogues in Bowes
cell membranes were in range from 0.1 to 50 WM
(data not shown), which is in accordance with above
mentioned data. On the other hand, other processes
than direct binding of the penetrating peptide to gal-
anin receptors could cause the estimated apparent
displacement of galanin from its receptors in Bowes
cell membranes by short analogues of TP. The un-
coupling of K-subunits of trimeric G-proteins from
galanin receptors and/or shifting receptors into low-
a⁄nity state towards galanin is highly probable,
since all these peptides (except TP10) in£uence the
basal GTPase activity of Bowes or Rin m5F cell
membranes. Moreover, the EC50 values of displace-
ment of galanin from its type 1 receptors and inhi-
bition of GTPase activity by TP are very close (17.4
and 21.1 WM, respectively) and may re£ect the same
process ^ interaction of peptide with G-proteins ^ in
di¡erent experimental setups.
N-terminal deletion of nine amino acids of TP
abolished the cellular uptake. The peptide TP11,
where amino acids 7^12 were deleted, showed weak
uptake at both temperatures used. Therefore it seems
that for e⁄cient uptake of TP derivatives, one of the
necessary regions of the molecule is the C-terminus
of the galanin part (middle part of TP).
It is known that mastoparan, the C-terminal part
of TP, is penetrating into cell membranes where it
creates short-living pores (cf. review [22]). An ana-
logue of TP, TP9, where two amino acids in the N-
terminus of mastoparan part are missing is taken up
by Bowes cells as well as TP. Since we observed that
truncation of the N-terminus of TP (TP7 and TP10)
does not in£uence the cellular uptake, we introduced
deletions by three (TP12) or six amino acids (TP14)
into the N-terminus of TP9. The uptake of both
peptides was signi¢cant, but somewhat lower than
for TP9 con¢rming once more that the N-terminal
part of TP is not the major determinant in penetra-
tion. In contrary, further shortening of mastoparan
derived part either from the N- (TP13) or C-terminus
(TP15) completely abolished the uptake. We con-
clude that two regions of TP molecule are necessary
for internalization: mastoparan part or at least 10 of
its amino acid residues and the C-terminal region of
the galanin-derived part or a certain length of this
region. We believe that the tyrosine moiety and the
amphipathic helix of mastoparan are probably the
motifs that are important for cellular uptake of TP
analogues. All peptides that showed signi¢cant cellu-
lar uptake contained tyrosine and three positive
charges in their sequences. Analogues without tyro-
sine or one positive charge in the C-terminal part did
not internalize. The data about accumulation of
short TP analogues obtained by indirect immuno-
£uorescence are in good correlation with the rate
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of internalization of these peptides estimated by us-
ing 125I-labeled peptides (Table 1). E⁄ciently up tak-
en peptides, TP and TP7 (+++ £uorescence inten-
sity), penetrate into cells quickly, the characteristic
times 3.4 and 4.3 min, respectively. Less e⁄cient pep-
tide TP12 (++) is internalizing at slower rate
d0:5 = 10.7 min. The rate of internalization enables
to distinguish the minute di¡erences in the penetra-
tion abilities of e⁄ciently penetrating peptides. The
highest rate of penetration has the longest peptide-
TP, shortening of the peptide causes slower internal-
ization. The correlation between the length of the
peptide and the rate of uptake is remarkable: longer
peptides penetrate quicker. Truncation of the peptide
in the same region led to proportional deceleration of
internalization: TP, TP7 and TP10 (d0:5 = 3.4; 4.3
and 8.6 min, respectively). However, the length of
the peptide is not the major determining factor for
internalization, since peptide TP9 with two amino
acids deletion penetrates into the cells slower than
TP7, which has three amino acid residues deleted
(d0:5 = 6.5 and 4.3 min, respectively). The same holds
true for peptides TP12 and TP10 with ¢ve and six
deleted amino acid residues, respectively, ^ shorter
peptide penetrates quicker. Therefore the length of
the peptide can not be considered the major determi-
nant for the cell-penetration e⁄ciency in the TP fam-
ily of peptides.
Scheller et al. [23] have studied the correlation be-
tween helix parameters, charge and molecular size
with the e⁄ciency of uptake of K-helical model pep-
tides into endothelial cells. They found that only the
amphipathicity of the K-helix of the peptide is im-
portant for the internalization and that the minimal
length of the peptide corresponds to four complete
helix turns (16 amino acids). We used the prediction
program Agadir [24] to calculate the extent of K-hel-
icity in TP derived peptide sequences. Only 29^50%
of the peptide molecule is predicted to be in the K-
helical structure that is located mostly in the middle
of the peptide chain. Helical wheel projections reveal
that all peptides, except TP15, have an amphipathic
structure, but there is no obvious correlation between
the internalization and amphipathicity.
TP and most of its penetrating analogues inhibit
the basal GTPase activity of Rin m5F membranes. It
is known that one building block of TP, mastoparan
activates and galanin does not a¡ect GTPase activity
[18,25]. The inhibition of GTPase activity by most
TP-derived peptides is similar to galparan, the pre-
cursor peptide of TP. Galparan is suggested to bind
with the C-terminus (mastoparan moiety) to the mas-
toparan binding site of the G-protein and with the
N-terminus to the allosteric site of GK subunit [18].
Wagner et al. [26] have suggested a structure for
peptide inhibitors of GTPase activity consisting of
a hydrophobic tail, which is covalently attached to
an amphiphilic moiety. All TP analogues, that inhibit
the GTPase activity, are composed of the amphi-
pathic helix extended with the hydrophobic tail of
galanin in the N-terminus, which is in good accord-
ance with the above-mentioned model. TP14, in con-
trast, has completely di¡erent biphasic e¡ect: a weak
activation and subsequent strong inhibition of basal
GTPase activity. We have shown a similar pattern of
GTPase activity modulation in Rin m5F cell mem-
branes for the chimeric peptides M375 and M391
that consist of vasopressin receptor V1 antagonist
and mastoparan connected directly or via 6-amino-
hexanoic acid [27]. Furthermore, we demonstrated
that these chimeric peptides stimulate GTPase activ-
ity of GKi/GKo and inhibit GKs protein [27]. The only
exception in this series of TP analogues is TP10 that
has no e¡ect on GTPase activity in Rin m5F cell
membranes.
In the peptide TP10 six amino acid residues from
TP’s N-terminus are missing and the mastoparan-
derived part is left intact. The absence of e¡ect on
GTPase activity was unexpected. In fact, TP10 does
not ¢t very well into Wagner’s model for GTPase
inhibitors of peptide character. TP10 has an amphi-
philic moiety-mastoparan part but the long hydro-
phobic tail that is present in other derivatives of
TP is missing or at least substantially shortened,
what could explain the absence of the inhibitory ef-
fect. On the other hand, TP10 can be interpreted as
N-terminally prolonged mastoparan, where seven ad-
ditional amino acids interfere in manifestation of
GTPase activating property of mastoparan. The
data, however, are too limited to draw any clear
conclusion about the mechanism involved in inhibi-
tion of GTPases by TP analogues and comprehensive
study is necessary to unravel the question.
Molecular modeling analysis shows that all TP
analogues have stable positions when inserted into
the membrane, but their orientations in relation to
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the membrane surface di¡er (Table 1 and Fig. 3).
Two predicted parameters can be correlated with
the ability of the peptides to traverse phospholipid
membranes. First, an oblique orientation relative to
the membrane plane seems to be important, since
peptides with more parallel orientation in relation
to the membrane (angle less than 40^45‡) are e⁄-
ciently internalizing. In contrast, short peptides (22
amino acids or less) with more perpendicular orien-
tation are poorly internalizing (TP11) if at all (TP13
and TP15).
TP and its derivatives of 24 or 25 amino acids, i.e.
long analogues penetrate into the cells most e⁄-
ciently. It seems that the increased length of the pep-
tide facilitates penetration into the hydrophobic core.
Shorter peptides (less than 21 residues) may not
reach the second lea£et, and are therefore too short
to span the lipid bilayer.
The di⁄culties in ¢nding unambiguous correlation
between the characteristics obtained from molecular
modeling of interaction of peptides with membrane
and experimental data on cell penetration of TP and
its analogues may be caused by plausible multimeri-
zation of these peptides. All analogues of TP form
dimers and higher oligomers in the presence of SDS
micelles [4] and could multimerize in the membranes
or interact with biological membranes as multimers
for e⁄cient membrane penetration as is suggested for
the antennapedia derived peptide [10].
Molecular modeling data show that the C-terminal
part of TP analogues is buried into the membrane,
only TP15 is an exception and has N-terminal in the
membrane. Both lysine residues of the C-terminus of
the longest peptides (TP, TP7 and TP9) may reach
the opposite side of the membrane. Consequently,
aromatic residues of the N-terminal and the biotinyl
group remain anchored in the ¢rst phospholipid po-
lar head area. According to the calculation of the
molecular hydrophobic potentials (MHP, [28]) the
N-terminal part is hydrophilic due to the presence
of threonine, serine or aromatic residues (Fig. 3).
According to the calculations, TP15 has an inverted
orientation, although this is the sole peptide that has
a charged hydrophilic lysine residue in the C-termi-
nal part. All other TP derivatives, in comparison,
have additional residues Lys-Ile-Leu in the C-termi-
nus. We conclude that the most important features,
which determine the orientation of cell penetrating
peptides in the membrane, are the peptide length,
but also the location of aromatic and lysine residues
in the terminal regions of the sequence.
In conclusion, we have synthesized several shorter
TP analogues that retain the e⁄cient cell penetration
property of the parent compound. One of these,
TP10, does not modulate the basal GTPase activity
even at very high concentrations nor is it recognized
by galanin receptors. These features make TP10 a
promising candidate for a new generation of trans-
port peptides with signi¢cantly less potential side ef-
fects.
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